Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4081

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for buPROPion HCL extended-release tablets, 150 mg strength, containing 180 tablets. The label includes the NDC number 70518-4081-00, manufacturer Camber Pharma, Inc., and repackager RemedyRepack Inc. Directions reference the package insert, with storage conditions noted. The label also features a barcode and a RemedyRepack logo.*
FDA Label Image

Bupropionhclstructure (Bupropionhclstructure)

Bupropionhclstructure (Bupropionhclstructure)
Chemical structure diagram of Bupropion hydrochloride showing its molecular framework including chlorine, ketone, and amine functional groups along with hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.